The War Goes On

The Science Business Blog at Forbes looks into what it dubs the “gene machine wars.” There, Matthew Herper points out that just weeks after Illumina announced that its HiSeq 2000 could sequence a human genome for about $10,000, that Life Technologies said its SOLiD 4 that could do it for $6,000. Herper says that Illumina won’t lose its place at the top.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.